Eisai Still Considering Next Steps After Australia Again Rejects Alzheimer’s Drug Leqembi
The Australian Therapeutic Goods Administration proposed a narrower indication that Eisai rejected.
The Australian Therapeutic Goods Administration proposed a narrower indication that Eisai rejected.